NATRIX Side Effects

6814550-1 | Blood Creatine Phosphokinase Increased, Dehydration, Hyperglycaemia, Renal Impairment
on Jun 24, 2010 Male patient from JAPAN , 27 years of age, was diagnosed with hypertension and was treated with Natrix (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatine phosphokinase increased, dehydration, hyperglycaemia, renal impairment. Natrix dosage: . During the same period patient was treated with MIGLITOL (View Miglitol Review and Miglitol Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), OLMETEC (View Olmetec Review and Olmetec Label ), SODIUM BICARBONATE (View Sodium Bicarbonate Review and Sodium Bicarbonate Label ), NU LOTAN (View Nu-lotan Review and Nu-lotan Label ), KREMEZIN (View Kremezin Review and Kremezin Label ). Patient was hospitalized.

6307384-8 | Myelodysplastic Syndrome, Pancytopenia
Patient was taking Natrix (View Usage). Patient had the following side effects: myelodysplastic syndrome, pancytopenia on Aug 07, 2009 from FRANCE Additional patient health information: Male patient , 74 years of age, . Natrix dosage: . During the same period patient was treated with MICARDIS (View Micardis Review and Micardis Label ), AROTINOLOL HYDROCHLORIDE (View Arotinolol Hydrochloride Review and Arotinolol Hydrochloride Label ). Patient was hospitalized.

5630942-0 | Eczema
Adverse event was reported on Feb 13, 2008 by a Female patient taking Natrix (View Usage) (Dosage: ) was diagnosed with hypertension and. Location: JAPAN , 48 years of age, weighting 87.30 lb, After Natrix was administered, patient had the following side effects: eczema (What is eczema?). During the same period patient was treated with BERIZYM /00517401/ (View Berizym /00517401/ Review and Berizym /00517401/ Label ), BIOFERMIN (View Biofermin Review and Biofermin Label ), LOPEMIN (View Lopemin Review and Lopemin Label ), GASTER (View Gaster Review and Gaster Label ), FOIPAN (View Foipan Review and Foipan Label ), CALCIUM POLYSTYRENE SULFONATE (View Calcium Polystyrene Sulfonate Review and Calcium Polystyrene Sulfonate Label ). Patient was hospitalized.

5630940-7 | Hypokalaemia, Ventricular Fibrillation
on Feb 13, 2008 Female patient from JAPAN , 78 years of age, weighting 101.4 lb, was diagnosed with hypertension, hypoaesthesia and was treated with Natrix (View Usage). Patient experienced the following unwanted or unexpected effects: hypokalaemia, ventricular fibrillation. Natrix dosage: . During the same period patient was treated with SHAKUYAKUKANZOUTOU (Dose: 1 Df) (View Shakuyakukanzoutou Review and Shakuyakukanzoutou Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), NU LOTAN (View Nu-lotan Review and Nu-lotan Label ), LANZOR (View Lanzor Review and Lanzor Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), METHYCOBAL /00056201/ (View Methycobal /00056201/ Review and Methycobal /00056201/ Label ), SELBEX (View Selbex Review and Selbex Label ).


5076656-X | Blood Urea Increased, Enteritis, Enterocolitis, Hypochloraemia, Hyponatraemia, Shock
on Apr 18, 2006 Female patient from JAPAN , 78 years of age, was diagnosed with hypertension and was treated with Natrix (View Usage). Patient had the following side effects: blood urea increased, enteritis, enterocolitis, hypochloraemia, hyponatraemia, shock. Natrix dosage: . During the same period patient was treated with COVERSYL (View Coversyl Review and Coversyl Label ), ASPENON (View Aspenon Review and Aspenon Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), DOGMATYL (View Dogmatyl Review and Dogmatyl Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), LANIRAPID (View Lanirapid Review and Lanirapid Label ), PANTOSIN (View Pantosin Review and Pantosin Label ).

5054763-5 | Back Pain, Blood Chloride Decreased, Blood Potassium Decreased, Convulsion, Decerebration, Glasgow Coma Scale Abnormal, Hyponatraemia, Rhabdomyolysis, Urinary Tract Infection
Patient was taking Natrix (View Usage). After Natrix was administered, patient had the following side effects: back pain (What is back pain?), blood chloride decreased, blood potassium decreased, convulsion, decerebration, glasgow coma scale abnormal, hyponatraemia, rhabdomyolysis, urinary tract infection (What is urinary tract infection?) on Jul 10, 2006 from JAPAN Additional patient health information: Male patient , 68 years of age, weighting 127.9 lb, was diagnosed with hypertension and. Natrix dosage: . During the same period patient was treated with NORVASC (View Norvasc Review and Norvasc Label ), TENORMIN (View Tenormin Review and Tenormin Label ), BLOPRESS (View Blopress Review and Blopress Label ). Patient was hospitalized.

4997211-3 | Cholecystitis, Pancreatic Carcinoma
Adverse event was reported on Apr 26, 2006 by a Male patient taking Natrix (View Usage) (Dosage: ) was diagnosed with ill-defined disorder, hypertension and. Location: JAPAN , weighting 141.1 lb, Patient experienced the following unwanted or unexpected effects: cholecystitis, pancreatic carcinoma. During the same period patient was treated with COVERSYL (Daily Dose: 4 Milligram(s)) (View Coversyl Review and Coversyl Label ), TENORMIN (View Tenormin Review and Tenormin Label ), AMLODIN (View Amlodin Review and Amlodin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), SYMMETREL (View Symmetrel Review and Symmetrel Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), MUCOSTA (View Mucosta Review and Mucosta Label ). Patient was hospitalized.

4983153-6 | Blood Urea Increased, Enterocolitis, Hyponatraemia, Shock
on Apr 18, 2006 Female patient from JAPAN , 78 years of age, was diagnosed with hypertension and was treated with Natrix (View Usage). Patient had the following side effects: blood urea increased, enterocolitis, hyponatraemia, shock. Natrix dosage: . During the same period patient was treated with COVERSYL (View Coversyl Review and Coversyl Label ), ASPENON (View Aspenon Review and Aspenon Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), DOGMATYL (View Dogmatyl Review and Dogmatyl Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), LANIRAPID (View Lanirapid Review and Lanirapid Label ), PANTOSIN (View Pantosin Review and Pantosin Label ).

4848123-7 | Erythema Multiforme
on Dec 02, 2005 Male patient from , 60 years of age, was diagnosed with hypertension and was treated with Natrix (View Usage). After Natrix was administered, patient had the following side effects: erythema multiforme. Natrix dosage: . During the same period patient was treated with LOXONIN (View Loxonin Review and Loxonin Label ), SELBEX (View Selbex Review and Selbex Label ), ALLEGRA (View Allegra Review and Allegra Label ). Patient was hospitalized.

4647263-5 | Bradycardia, Loss Of Consciousness, Renal Failure Acute
Patient was taking Natrix (View Usage). Patient experienced the following unwanted or unexpected effects: bradycardia, loss of consciousness, renal failure acute on Apr 21, 2005 from Additional patient health information: Male patient , 82 years of age, was diagnosed with hypertension and. Natrix dosage: . During the same period patient was treated with COVERSYL (View Coversyl Review and Coversyl Label ), ZYLORIC (View Zyloric Review and Zyloric Label ), PANALDINE (View Panaldine Review and Panaldine Label ), DEPAS (View Depas Review and Depas Label ), GASTER (View Gaster Review and Gaster Label ), NIVADIL (View Nivadil Review and Nivadil Label ). Patient was hospitalized.

4565142-9 | Dermatitis Exfoliative, Erythema, Hypoaesthesia, Lymphocyte Stimulation Test Positive, Photosensitivity Reaction, Pruritus, Skin Swelling
Adverse event was reported on Jan 20, 2005 by a Male patient taking Natrix (View Usage) (Dosage: ) was diagnosed with hypertension and. Location: , 66 years of age, Patient had the following side effects: dermatitis exfoliative, erythema, hypoaesthesia, lymphocyte stimulation test positive, photosensitivity reaction, pruritus, skin swelling. During the same period patient was treated with MAINTATE (View Maintate Review and Maintate Label ), FLUITRAN (View Fluitran Review and Fluitran Label ), DIOVAN (View Diovan Review and Diovan Label ), RIBALL (View Riball Review and Riball Label ).

4562374-0 | Dermatitis Exfoliative, Lymphocyte Stimulation Test Positive
on Jan 20, 2005 Male patient from , 66 years of age, was diagnosed with hypertension and was treated with Natrix (View Usage). After Natrix was administered, patient had the following side effects: dermatitis exfoliative, lymphocyte stimulation test positive. Natrix dosage: . During the same period patient was treated with MAINTATE (View Maintate Review and Maintate Label ), FLUITRAN (View Fluitran Review and Fluitran Label ), DIOVAN (View Diovan Review and Diovan Label ), RIBALL (View Riball Review and Riball Label ).